Hence, studies that explore modalities that affect COMP expression, alleviate extracellular matrix rigidity and lung restriction in IPF and interfere with the amplification of TGF-β1 signaling should be persuaded. The gene discussed is COMP; the disease is idiopathic pulmonary fibrosis.